Microdose GLP-1 is lower-dose compounded semaglutide or tirzepatide (weekly injection or daily tablet), prescribed online by licensed providers. Starts at $69/mo on a 12-month plan ($828 billed up front), or $99 month to month. One price per plan covers the visit, prescription, medication and shipping. No membership fee. Semaglutide is the active ingredient in Wegovy® and Ozempic® (Novo Nordisk); tirzepatide, in Zepbound® and Mounjaro® (Eli Lilly). Compounded medications are not FDA-approved. Choose a 1-, 3-, 6- or 12-month plan: $99 a month on a 1-month plan, $89/mo for 3 months ($267), $79/mo for 6 months ($474) or $69/mo for 12 months ($828). 3-, 6- and 12-month plans are charged once, up front, and renew automatically. Cancel future renewals anytime. Same price whichever microdose you choose. The optional GLP-1 & Peptide Pathways Genetic Test analyzes 34 Weight Management insights, including FTO rs9939609, drawn from a 150+ insight panel across 14 pathways. It is a $99 add-on after your first month of treatment. It does not recommend, prescribe or determine which medication you use; your provider does. Starting at: $69/mo (12-month plan, $828 billed up front · $99 month to month) Dosing: Provider-determined (you choose semaglutide or tirzepatide, shot or tablet) Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. PlexusDx is not affiliated with or endorsed by Novo Nordisk A/S or Eli Lilly and Company.
